{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:08:51Z","timestamp":1792789731466,"version":"4.5.0"},"reference-count":85,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education of the Russian Federation","award":["FGFU-2022-00008"],"award-info":[{"award-number":["FGFU-2022-00008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Atherosclerosis is an insidious vascular disease with an asymptomatic debut and development over decades. The aetiology and pathogenesis of atherosclerosis are not completely clear. However, chronic inflammation and autoimmune reactions play a significant role in the natural course of atherosclerosis. The pathogenesis of atherosclerosis involves damage to the intima, immune cell recruitment and infiltration of cells such as monocytes\/macrophages, neutrophils, and lymphocytes into the inner layer of vessel walls, and the accumulation of lipids, leading to vascular inflammation. The recruited immune cells mainly have a pro-atherogenic effect, whereas CD4+ regulatory T (Treg) cells are another heterogeneous group of cells with opposite functions that suppress the pathogenic immune responses. Present in low numbers in atherosclerotic plaques, Tregs serve a protective role, maintaining immune homeostasis and tolerance by suppressing pro-inflammatory immune cell subsets. Compelling experimental data suggest that various Treg cell-based approaches may be important in the treatment of atherosclerosis. Here we highlight the most recent advances in our understanding of the roles of FOXP3-expressing CD4+ Treg cells in the atherogenic process and discuss potential translational strategies for the treatment of atherosclerosis by Treg manipulation.<\/jats:p>","DOI":"10.3390\/life13091931","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T02:26:17Z","timestamp":1695090377000},"page":"1931","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3920-7581","authenticated-orcid":false,"given":"Alexey V.","family":"Churov","sequence":"first","affiliation":[{"name":"Institute on Aging Research, Russian Gerontology Clinical Research Center, Pirogov Russian National Research Medical University, 129226 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yegor S.","family":"Chegodaev","sequence":"additional","affiliation":[{"name":"Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2096-3237","authenticated-orcid":false,"given":"Victoria A.","family":"Khotina","sequence":"additional","affiliation":[{"name":"Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8055-3785","authenticated-orcid":false,"given":"Vladimir P.","family":"Ofitserov","sequence":"additional","affiliation":[{"name":"Moscow Aviation Institute, National Research University, 4 Volokolamskoe Shosse, 125993 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3318-4681","authenticated-orcid":false,"given":"Alexander N.","family":"Orekhov","sequence":"additional","affiliation":[{"name":"Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Hansson","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00018-015-2080-2","article-title":"Regulatory T cells in atherosclerosis: Critical immune regulatory function and therapeutic potential","volume":"73","author":"Spitz","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.20517\/2574-1209.2018.44","article-title":"A current view of G protein-coupled receptor\u2014Mediated signaling in pulmonary hypertension: Finding opportunities for therapeutic intervention","volume":"2","author":"Strassheim","year":"2018","journal-title":"Vessel Plus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coi.2020.07.004","article-title":"New Treg cell-based therapies of autoimmune diseases: Towards antigen-specific immune suppression","volume":"67","author":"Mikami","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1007\/s11033-021-06483-x","article-title":"Treg cells in atherosclerosis","volume":"48","author":"Kuan","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.15690\/vramn656","article-title":"Subpopulations of regulatory T-lymphocytes in the peripheral blood of patients with rheumatoid arthritis","volume":"71","author":"Kravchenko","year":"2016","journal-title":"Ann. Russ. Acad. Med. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"109201","DOI":"10.1016\/j.clim.2022.109201","article-title":"Regulatory T cell homeostasis: Requisite signals and implications for clinical development of biologics","volume":"246","author":"Skartsis","year":"2023","journal-title":"Clin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.193.11.1303","article-title":"Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood","volume":"193","author":"Dieckmann","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q","article-title":"Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells","volume":"32","author":"Taams","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/eji.200526189","article-title":"Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level","volume":"35","author":"Roncador","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","article-title":"Regulatory T Cells: The Many Faces of Foxp3","volume":"39","author":"Georgiev","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.it.2016.11.004","article-title":"Transcriptional Regulation of Tissue-Resident Lymphocytes","volume":"38","author":"Mackay","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"364710","DOI":"10.1155\/2015\/364710","article-title":"Decreased regulatory T cells in vulnerable atherosclerotic lesions: Imbalance between pro- and anti-inflammatory cells in atherosclerosis","volume":"2015","author":"Rohm","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"ref_21","first-page":"189","article-title":"The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells","volume":"3","author":"Yi","year":"2006","journal-title":"Cell. Mol. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1091\/mbc.e11-12-1018","article-title":"GARP regulates the bioavailability and activation of TGF\u03b2","volume":"23","author":"Wang","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"42826","DOI":"10.18632\/oncotarget.8753","article-title":"GARP: A surface molecule of regulatory T cells that is involved in the regulatory function and TGF-\u03b2 releasing","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7909407","DOI":"10.1155\/2017\/7909407","article-title":"Decreased Helios Expression in Regulatory T Cells in Acute Coronary Syndrome","volume":"2017","author":"Jiang","year":"2017","journal-title":"Dis. Markers"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","journal-title":"Immunity"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells","volume":"45","author":"Arrigoni","year":"2016","journal-title":"Immunity"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12265-015-9608-6","article-title":"Function of CD147 in atherosclerosis and atherothrombosis","volume":"8","author":"Wang","year":"2015","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Salomon","year":"2006","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI63891","article-title":"Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis","volume":"123","author":"Klingenberg","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"De Boer, O.J., van der Meer, J.J., Teeling, P., van der Loos, C.M., and van der Wal, A.C. (2007). Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000779"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.atherosclerosis.2012.03.016","article-title":"Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques","volume":"222","author":"George","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00011-012-0510-2","article-title":"Increased Th17 cell frequency concomitant with decreased Foxp3+ Treg cell frequency in the peripheral circulation of patients with carotid artery plaques","volume":"61","author":"Liu","year":"2012","journal-title":"Inflamm. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2013.06.014","article-title":"Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells","volume":"230","author":"Dietel","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1038\/s41598-017-15546-8","article-title":"Hypercholesterolemia enhances T cell receptor signaling and increases the regulatory T cell population","volume":"7","author":"Mailer","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.1097\/01.hjh.0000571964.05863.90","article-title":"FOXP3+ T-regulatory lymphocytes in hypertensive patients association with coronary atherosclerosis","volume":"37","author":"Kologrivova","year":"2019","journal-title":"J. Hypertens."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1159\/000362963","article-title":"Ox-LDL influences peripheral Th17\/Treg balance by modulating Treg apoptosis and Th17 proliferation in atherosclerotic cerebral infarction","volume":"33","author":"Li","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"34157","DOI":"10.1074\/jbc.M112.382978","article-title":"Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome","volume":"287","author":"Zhang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/eurheartj\/eht543","article-title":"Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes","volume":"36","author":"Klingenberg","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/CIRCRESAHA.116.309764","article-title":"Atherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFN\u03b3+ Th1\/Tregs","volume":"119","author":"Butcher","year":"2016","journal-title":"Circ. Res."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zhu, Z.F., Meng, K., Zhong, Y.C., Qi, L., Mao, X.B., Yu, K.W., Zhang, W., Zhu, P.F., Ren, Z.P., and Wu, B.W. (2014). Impaired circulating CD4+LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088775"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1194\/jlr.D000497","article-title":"The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation","volume":"51","author":"Lin","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2011.04.029","article-title":"Differential effects of regulatory T cells on the initiation and regression of atherosclerosis","volume":"218","author":"Foks","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.ijcard.2013.03.026","article-title":"Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice","volume":"168","author":"Meng","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.CIR.0000089083.61317.A1","article-title":"Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice","volume":"108","author":"Mallat","year":"2003","journal-title":"Circulation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/ATVBAHA.109.186593","article-title":"TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice","volume":"29","author":"Frutkin","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/JLB.MR1117-469R","article-title":"Follicular regulatory T cell in atherosclerosis","volume":"104","author":"Baptista","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2016.09.042","article-title":"Human regulatory B cells control the TFH cell response","volume":"140","author":"Achour","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: A molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1172\/JCI31344","article-title":"Proatherogenic immune responses are regulated by the PD-1\/PD-L pathway in mice","volume":"117","author":"Gotsman","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1053\/j.gastro.2012.07.116","article-title":"Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn\u2019s disease","volume":"143","author":"Desreumaux","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","article-title":"Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets\u2014Results of one year follow-up","volume":"153","author":"Dobyszuk","year":"2014","journal-title":"Clin. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/ehjcvp\/pvw001","article-title":"Targeting T cells to treat atherosclerosis: Odyssey from bench to bedside","volume":"2","author":"Bullenkamp","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.atherosclerosis.2010.01.043","article-title":"Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis","volume":"211","author":"Volger","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1189\/jlb.2RI0814-408R","article-title":"mTOR and metabolic regulation of conventional and regulatory T cells","volume":"97","author":"Liu","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/039463201202500209","article-title":"Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice","volume":"25","author":"Huang","year":"2012","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.numecd.2009.07.010","article-title":"Pioglitazone modulates the balance of effector and regulatory T cells in apolipoprotein E deficient mice","volume":"21","author":"Tian","year":"2011","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/ATVBAHA.110.215459","article-title":"Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions","volume":"30","author":"Takeda","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCULATIONAHA.110.006411","article-title":"Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia","volume":"124","author":"Tarrio","year":"2011","journal-title":"Circulation"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbrc.2011.06.162","article-title":"Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells","volume":"411","author":"Jiagang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cvr\/cvu002","article-title":"Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice","volume":"102","author":"Kita","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e000719","DOI":"10.1161\/JAHA.113.000719","article-title":"CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response","volume":"3","author":"Kasahara","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.yjmcc.2011.12.016","article-title":"Role of regulatory T cells in atheroprotective effects of granulocyte colony-stimulating factor","volume":"52","author":"Uchiyama","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coi.2019.02.008","article-title":"Vaccination against atherosclerosis","volume":"59","author":"Kobiyama","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/ATVBAHA.107.151274","article-title":"Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis","volume":"27","author":"Habets","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41598-018-19621-6","article-title":"Generation and Characterization of Alloantigen-Specific Regulatory T Cells for Clinical Transplant Tolerance","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2018.05.003","article-title":"Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells","volume":"92","author":"Kim","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3389\/fimmu.2017.01117","article-title":"Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision","volume":"8","author":"Adair","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3389\/fimmu.2018.02359","article-title":"Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.atherosclerosis.2019.06.050","article-title":"Engineered Regulatory T Cell Adoptive Therapy As A Novel Tool For The Treatment Of Atherosclerosis","volume":"287","author":"Bonacina","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/ajt.12433","article-title":"Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation","volume":"13","author":"Putnam","year":"2013","journal-title":"Am. J. Transpl."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"eaaw0902","DOI":"10.1126\/sciimmunol.aaw0902","article-title":"CTLA-4\u2013mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells","volume":"4","author":"Ovcinnikovs","year":"2019","journal-title":"Sci. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1042\/BST20150247","article-title":"Antigen-specificity using chimeric antigen receptors: The future of regulatory T-cell therapy?","volume":"44","author":"Boardman","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/stem.2715","article-title":"Concise review: Emerging principles from the clinical application of chimeric antigen receptor T cell therapies for B cell malignancies","volume":"36","author":"Jain","year":"2018","journal-title":"Stem Cells"},{"key":"ref_77","first-page":"93","article-title":"Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives","volume":"65","author":"Gauthier","year":"2017","journal-title":"Curr. Res. Transl. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s13238-017-0410-x","article-title":"Advancing chimeric antigen receptor T cell therapy with CRISPR\/Cas9","volume":"8","author":"Ren","year":"2017","journal-title":"Protein Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"655122","DOI":"10.3389\/fimmu.2021.655122","article-title":"Fast and Efficient Genome Editing of Human FOXP3+ Regulatory T Cells","volume":"12","author":"Hamad","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13072-017-0129-1","article-title":"Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells","volume":"10","author":"Okada","year":"2017","journal-title":"Epigenet. Chromatin"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Wang, P., Zheng, L., Qiao, M., Zhao, T., Zhang, R., and Dong, H. (2022). A Single-Cell Atlas of the Atherosclerotic Plaque in the Femoral Artery and the Heterogeneity in Macrophage Subtypes between Carotid and Femoral Atherosclerosis. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9120465"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41569-021-00589-2","article-title":"Immune cell profiling in atherosclerosis: Role in research and precision medicine","volume":"19","author":"Fernandez","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","article-title":"Single-cell immune landscape of human atherosclerotic plaques","volume":"25","author":"Fernandez","year":"2019","journal-title":"Nat. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/CIRCRESAHA.120.316770","article-title":"Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics","volume":"127","author":"Depuydt","year":"2020","journal-title":"Circ. Res."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/9\/1931\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:53:10Z","timestamp":1760129590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/9\/1931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":85,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["life13091931"],"URL":"https:\/\/doi.org\/10.3390\/life13091931","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]}}}